Bradley G Hammill

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. doi request reprint Performance of propensity score methods when comparison groups originate from different data sources
    Bradley G Hammill
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Pharmacoepidemiol Drug Saf 21:81-9. 2012
  2. pmc Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries
    Bradley G Hammill
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Circulation 121:63-70. 2010
  3. doi request reprint Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization
    Bradley G Hammill
    Duke Clinical Research Institute and Department of Medicine, Duke University School of Medicine, Durham, NC 27715, USA
    Circ Cardiovasc Qual Outcomes 4:60-7. 2011
  4. doi request reprint Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction
    Adrian F Hernandez
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
    JAMA 308:2097-107. 2012
  5. doi request reprint Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims
    Robb D Kociol
    Duke Clinical Research Institute, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA
    Clin Cardiol 34:682-8. 2011
  6. pmc Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries
    Adrian F Hernandez
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    JAMA 300:2398-406. 2008
  7. doi request reprint Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure
    Lesley H Curtis
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC Department of Medicine, Duke University School of Medicine, Durham, NC Electronic address
    Am Heart J 165:979-986.e1. 2013
  8. pmc Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation
    Jonathan P Piccini
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Circulation 126:2200-7. 2012
  9. pmc Relationships between emerging measures of heart failure processes of care and clinical outcomes
    Adrian F Hernandez
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Am Heart J 159:406-13. 2010
  10. doi request reprint Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure
    Robb D Kociol
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
    Am J Cardiol 108:985-91. 2011

Detail Information

Publications61

  1. doi request reprint Performance of propensity score methods when comparison groups originate from different data sources
    Bradley G Hammill
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Pharmacoepidemiol Drug Saf 21:81-9. 2012
    ..To examine the performance of propensity score-based methods for estimating relative risks when exposed and comparison subjects are selected from different data sources...
  2. pmc Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries
    Bradley G Hammill
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Circulation 121:63-70. 2010
    ..The relationship between the number of sessions attended and long-term outcomes is unknown...
  3. doi request reprint Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization
    Bradley G Hammill
    Duke Clinical Research Institute and Department of Medicine, Duke University School of Medicine, Durham, NC 27715, USA
    Circ Cardiovasc Qual Outcomes 4:60-7. 2011
    ..As clinical data become more readily available, the incremental value of adding clinical data to claims-based models of mortality and readmission is unclear...
  4. doi request reprint Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction
    Adrian F Hernandez
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
    JAMA 308:2097-107. 2012
    ..Aldosterone antagonist therapy for heart failure and reduced ejection fraction has been highly efficacious in randomized trials. However, questions remain regarding the effectiveness and safety of the therapy in clinical practice...
  5. doi request reprint Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims
    Robb D Kociol
    Duke Clinical Research Institute, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA
    Clin Cardiol 34:682-8. 2011
    ..Although pharmacologic prophylaxis regimens have reduced VTE risk in medically ill patients, associations with early postdischarge adverse clinical outcomes among patients with heart failure are unknown...
  6. pmc Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries
    Adrian F Hernandez
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    JAMA 300:2398-406. 2008
    ..In 2003, Medicare expanded coverage of ventricular assist devices as destination, or permanent, therapy for end-stage heart failure. Little is known about the long-term outcomes and costs associated with these devices...
  7. doi request reprint Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure
    Lesley H Curtis
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC Department of Medicine, Duke University School of Medicine, Durham, NC Electronic address
    Am Heart J 165:979-986.e1. 2013
    ..Aldosterone antagonist therapy is recommended for selected patients with heart failure and reduced ejection fraction. Adherence to therapy in the transition from hospital to home is not well understood...
  8. pmc Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation
    Jonathan P Piccini
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Circulation 126:2200-7. 2012
    ..Atrial fibrillation is common among older persons. Catheter ablation is increasingly used in patients for whom medical therapy has failed...
  9. pmc Relationships between emerging measures of heart failure processes of care and clinical outcomes
    Adrian F Hernandez
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Am Heart J 159:406-13. 2010
    ..Previous studies have not confirmed associations between some current performance measures for inpatient heart failure processes of care and postdischarge outcomes. It is unknown if alternative measures are associated with outcomes...
  10. doi request reprint Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure
    Robb D Kociol
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
    Am J Cardiol 108:985-91. 2011
    ..Strategies are needed to ensure access among vulnerable populations to this supply-sensitive resource...
  11. doi request reprint Clinical effectiveness of anticoagulation therapy among older patients with heart failure and without atrial fibrillation: findings from the ADHERE registry linked to Medicare claims
    Adrian F Hernandez
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
    J Card Fail 19:401-7. 2013
    ..Patients with heart failure are at higher risk for thromboembolic events, even in the absence of atrial fibrillation, but the effect of anticoagulation therapy on outcomes is uncertain...
  12. doi request reprint Design and rationale of a retrospective clinical effectiveness study of aldosterone antagonist therapy in patients with heart failure
    Lesley H Curtis
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
    Am Heart J 163:946-953.e1. 2012
    ..Questions remain about its clinical effectiveness and safety for patients who are underrepresented in randomized trials and those at risk for hyperkalemia...
  13. doi request reprint B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry
    Robb D Kociol
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Am Heart J 163:994-1001. 2012
    ..Associations between BNP level and thromboembolic events in patients with HF without atrial fibrillation (AF) are not well studied...
  14. pmc Representativeness of a national heart failure quality-of-care registry: comparison of OPTIMIZE-HF and non-OPTIMIZE-HF Medicare patients
    Lesley H Curtis
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Circ Cardiovasc Qual Outcomes 2:377-84. 2009
    ..Participation in clinical registries is nonrandom, so participants may differ in important ways from nonparticipants. The extent to which findings from clinical registries can be generalized to broader populations is unclear...
  15. ncbi request reprint Patient-reported frequency of taking aspirin in a population with coronary artery disease
    Nancy M Allen LaPointe
    Duke CERTs Centers for Education and Research on Therapeutics at the Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    Am J Cardiol 89:1042-6. 2002
    ..Although the rate of aspirin use in this population was higher than previously reported, an estimated 6% of eligible patients were not receiving antiplatelet therapy...
  16. doi request reprint National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines-Heart Failure registry
    Robb D Kociol
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Circ Heart Fail 5:680-7. 2012
    ..Reducing 30-day heart failure readmission rates is a national priority. Yet, little is known about how hospitals address the problem and whether hospital-based processes of care are associated with reductions in readmission rates...
  17. doi request reprint Treatment patterns for neovascular age-related macular degeneration: analysis of 284 380 medicare beneficiaries
    Lesley H Curtis
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
    Am J Ophthalmol 153:1116-24.e1. 2012
    ..To examine trends in the treatment of newly diagnosed neovascular age-related macular degeneration (AMD)...
  18. pmc Predicting costs among medicare beneficiaries with heart failure
    Melissa A Greiner
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
    Am J Cardiol 109:705-11. 2012
    ..In conclusion, a model based on variables from clinical registries can identify a group of patients with heart failure who on average will incur higher costs in the first year after hospitalization...
  19. doi request reprint Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure
    Adrian F Hernandez
    Duke Clinical Research Institute, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
    Circ Heart Fail 3:7-13. 2010
    ..The clinical effectiveness of implantable cardioverter-defibrillators (ICDs) in older patients with heart failure has not been established, and older patients have been underrepresented in previous studies...
  20. doi request reprint Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database
    John L Petersen
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Am Heart J 159:462-470.e1. 2010
    ..Relationships between long-term use and level of dual antiplatelet therapy and outcomes after drug-eluting stent implantation are not well established...
  21. doi request reprint Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure
    Adrian F Hernandez
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    JAMA 303:1716-22. 2010
    ..However, there are limited data describing patterns of follow-up after heart failure hospitalization and its association with readmission rates...
  22. doi request reprint Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure
    Robb D Kociol
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Am J Cardiol 105:1786-93. 2010
    ..12, 95% confidence interval 1.04 to 1.20) but not readmission or total inpatient costs. In conclusion, worsening RF in patients hospitalized with HF was independently associated with long-term mortality...
  23. doi request reprint Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy
    Alisa M Shea
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    JAMA 300:189-96. 2008
    ..Anecdotal reports suggest that these adjustments may have negatively affected access to chemotherapy for Medicare beneficiaries...
  24. doi request reprint Costs of newly diagnosed neovascular age-related macular degeneration among medicare beneficiaries, 2004-2008
    Laura G Qualls
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
    Retina 33:854-61. 2013
    ..To examine associations between newly diagnosed neovascular age-related macular degeneration and direct medical costs...
  25. pmc Linking inpatient clinical registry data to Medicare claims data using indirect identifiers
    Bradley G Hammill
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
    Am Heart J 157:995-1000. 2009
    ..We present a method to link hospitalization records from registries with Medicare inpatient claims data, without using direct identifiers, to create a unique data source that pairs rich clinical data with long-term outcome data...
  26. doi request reprint Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation
    Zubin J Eapen
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina Department of Medicine, Duke University School of Medicine, Durham, North Carolina Electronic address
    J Card Fail 20:23-30. 2014
    ..Postdischarge adherence and long-term persistence in the use of warfarin among patients with heart failure and atrial fibrillation without contraindications have not been fully described...
  27. doi request reprint Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score
    Matthew T Roe
    Duke Clinical Research Institute, Durham, NC, USA
    Am Heart J 162:875-883.e1. 2011
    ..We sought to develop a long-term mortality risk prediction model and a simplified risk score for use in older patients with non-ST-segment elevation myocardial infarction (NSTEMI)...
  28. pmc Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007
    Jonathan P Piccini
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
    Circ Cardiovasc Qual Outcomes 5:85-93. 2012
    ..The frequency of AF increases with age, but representative national data about incidence and prevalence are limited. We examined the annual incidence, prevalence, and mortality associated with AF among older persons...
  29. doi request reprint Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries
    Robb D Kociol
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Am Heart J 160:885-92. 2010
    ..Clinical registries are used increasingly to analyze quality and outcomes, but the generalizability of findings from registries is unclear...
  30. doi request reprint Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006
    Michaela A Dinan
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    JAMA 303:1625-31. 2010
    ..Imaging is the fastest growing expense for Medicare but has not been examined among beneficiaries with cancer...
  31. doi request reprint Resource use and costs of branch and central retinal vein occlusion in the elderly
    Sharon Fekrat
    Duke University School of Medicine, Durham, NC, USA 27715
    Curr Med Res Opin 26:223-30. 2010
    ..To examine the incidence, prevalence, resource use, and costs associated with branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) in elderly patients...
  32. pmc Process of care performance measures and long-term outcomes in patients hospitalized with heart failure
    Mark E Patterson
    Center for Clinical and Genetic Economics, Duke University School of Medicine, Durham, NC, USA
    Med Care 48:210-6. 2010
    ..Recent efforts to improve care for patients hospitalized with heart failure have focused on process-based performance measures. Data supporting the link between current process measures and patient outcomes are sparse...
  33. pmc External validity of the cardiovascular health study: a comparison with the Medicare population
    Lisa D DiMartino
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
    Med Care 47:916-23. 2009
    ..The Cardiovascular Health Study (CHS), a population-based prospective cohort study, has been used to identify major risk factors associated with cardiovascular disease and stroke in the elderly...
  34. doi request reprint Incidence and prevalence of heart failure in elderly persons, 1994-2003
    Lesley H Curtis
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
    Arch Intern Med 168:418-24. 2008
    ..We sought to estimate the annual incidence and prevalence of heart failure and associated survival in elderly persons from January 1, 1994, through December 31, 2003...
  35. pmc Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry
    Adrian F Hernandez
    Duke Clinical Research Institute, Durham, NC 27715, USA
    J Am Coll Cardiol 53:184-92. 2009
    ..We sought to examine associations between initiation of beta-blocker therapy and outcomes among elderly patients hospitalized for heart failure...
  36. doi request reprint Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke
    Jonathan P Piccini
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Eur Heart J 35:250-6. 2014
    ..However, the relative event rates for these outcomes are not well described. We sought to define the risks of major clinical events in older adults after a new diagnosis of atrial fibrillation...
  37. doi request reprint Impact of immortal person-time and time scale in comparative effectiveness research for medical devices: a case for implantable cardioverter-defibrillators
    Xiaojuan Mi
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
    J Clin Epidemiol 66:S138-44. 2013
    ..To assess the extent of immortal time bias in estimating the clinical effectiveness of implantable cardioverter-defibrillators (ICDs) and the impact of methods of handling immortal time bias...
  38. pmc Assessment of left ventricular function in older Medicare beneficiaries with newly diagnosed heart failure
    Lesley H Curtis
    Duke Clinical Research Institute and Department of Medicine, Duke University School of Medicine, Durham, NC 27715, USA
    Circ Cardiovasc Qual Outcomes 4:85-91. 2011
    ..Little is known about the extent to which left ventricular function is assessed in real-world settings...
  39. ncbi request reprint Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease
    L Kristin Newby
    Centers for Education and Research on Therapeutics, Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
    Circulation 113:203-12. 2006
    ..Studies have examined the use of evidence-based therapies for coronary artery disease (CAD) in the short term and at hospital discharge, but few have evaluated long-term use...
  40. doi request reprint Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration
    Lesley H Curtis
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
    Arch Ophthalmol 128:1273-9. 2010
    ..To examine associations between therapies for age-related macular degeneration and risks of all-cause mortality, incident myocardial infarction, bleeding, and incident stroke...
  41. ncbi request reprint Pancreatic beta-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health Study
    Lesley H Curtis
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
    Curr Med Res Opin 24:41-50. 2008
    ..To explore relationships between beta-cell function and incident cardiovascular events, death, and medical costs among elderly individuals...
  42. pmc Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure
    Zubin J Eapen
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC
    J Am Heart Assoc 2:e000242. 2013
    ..Dispensing data from Medicare Part D standalone prescription drug plans are now available, but characteristics of enrollees with heart failure have not been well described...
  43. ncbi request reprint Multifaceted intervention to promote beta-blocker use in heart failure
    Nancy M Allen LaPointe
    Center for Education and Research on Therapeutics, Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 151:992-8. 2006
    ..Despite a survival benefit and guideline recommendation for beta-blockers in left ventricular systolic dysfunction, beta-blockers are underused in clinical practice...
  44. ncbi request reprint Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death
    Lesley H Curtis
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
    JAMA 298:1517-24. 2007
    ..Previous studies of sex differences in the use of implantable cardioverter-defibrillators (ICDs) predate recent expansions in Medicare coverage and did not provide patient follow-up over multiple years...
  45. pmc Early and long-term outcomes of heart failure in elderly persons, 2001-2005
    Lesley H Curtis
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
    Arch Intern Med 168:2481-8. 2008
    ..The treatment of chronic heart failure has improved during the past 2 decades, but little is known about whether the improvements are reflected in trends in early and long-term mortality and hospital readmission...
  46. ncbi request reprint Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases
    Lesley H Curtis
    Duke Clinical Research Institute, and Departments of Medicine, Duke University School of Medicine, Durham, North Carolina, USA
    Med Care 45:S103-7. 2007
    ..Finally, we offer detailed guidance about how to implement the estimators in comparative effectiveness analyses...
  47. pmc Recognition of CKD After the Introduction of Automated Reporting of Estimated GFR in the Veterans Health Administration
    Virginia Wang
    Durham Veterans Affairs Medical Center, Durham, North Carolina, Duke University, Durham, North Carolina, Western University, London, Ontario, Canada
    Clin J Am Soc Nephrol 9:29-36. 2014
    ..Automated laboratory reporting of estimated GFR (eGFR) has been introduced in many health systems to improve CKD recognition, but its effect in large, United States-based health systems remains unclear...
  48. doi request reprint Impact of heart failure on patients undergoing major noncardiac surgery
    Bradley G Hammill
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, North Carolina, USA
    Anesthesiology 108:559-67. 2008
    ..The authors evaluated short-term outcomes among patients with heart failure, coronary artery disease (CAD), or neither who underwent major noncardiac surgery...
  49. pmc Medical costs of abnormal serum sodium levels
    Alisa M Shea
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    J Am Soc Nephrol 19:764-70. 2008
    ..2%). Costs associated with hypernatremia were not significantly different from those incurred by patients with normal serum sodium. In conclusion, hyponatremia is a significant independent predictor of 6-mo and 1-yr direct medical costs...
  50. pmc A survey of health care practitioners' knowledge of the QT interval
    Sana M Al-Khatib
    Duke Center for Education and Research on Therapeutics, Duke Clinical Research Institute, Durham, NC 27715, USA
    J Gen Intern Med 20:392-6. 2005
    ..To assess health care practitioners' ability to correctly measure the QT interval, and to identify factors and medications that may increase the risk of QT-interval prolongation and torsades de pointes...
  51. ncbi request reprint A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database
    Adrian F Hernandez
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Circulation 116:606-12. 2007
    ..We examined a large national clinical database to assess trends in the incidence of post-cardiac surgery shock requiring VAD implantation, survival rates, and risk factors for mortality...
  52. pmc Resource use and costs associated with diabetic macular edema in elderly persons
    Alisa M Shea
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
    Arch Ophthalmol 126:1748-54. 2008
    ..To examine trends in resource use and the effect of incident diabetic macular edema (DME) on 1- and 3-year total direct medical costs in elderly patients...
  53. pmc Physiological and psychosocial factors that predict HIV-related fatigue
    Julie Barroso
    School of Nursing, Duke University, DUMC 3322, Durham, NC 27710, USA
    AIDS Behav 14:1415-27. 2010
    ..Physiological variables did not predict greater fatigue. Stressful life events had both direct and indirect effects on fatigue...
  54. doi request reprint Data sources for heart failure comparative effectiveness research
    Ying Xian
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
    Heart Fail Clin 9:1-13. 2013
    ..Advancing the infrastructure to provide robust, scientific data resources for patient-centered CER must remain a priority...
  55. ncbi request reprint Costs of the metabolic syndrome in elderly individuals: findings from the Cardiovascular Health Study
    Lesley H Curtis
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, P O Box 17969, Durham, NC 27715, USA
    Diabetes Care 30:2553-8. 2007
    ..Little is known about how the metabolic syndrome and its individual components translate into long-term medical costs...
  56. pmc Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials
    Michaela A Dinan
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Med Care 49:415-9. 2011
    ....
  57. pmc Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures
    Michaela A Dinan
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
    Am J Hematol 84:703-9. 2009
    ..Patients with SCD who underwent cholecystectomy or hip replacement required more health care resources than patients without SCD. Am. J. Hematol. 2009. (c) 2009 Wiley-Liss, Inc...
  58. ncbi request reprint The Medicare Modernization Act and reimbursement for outpatient chemotherapy: do patients perceive changes in access to care?
    Joeëlle Y Friedman
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    Cancer 110:2304-12. 2007
    ....
  59. pmc Implementation of automated reporting of estimated glomerular filtration rate among Veterans Affairs laboratories: a retrospective study
    Rasheeda K Hall
    Center for Health Services Research in Primary Care, Veterans Affairs Health Services Research and Development, Durham, NC, USA
    BMC Med Inform Decis Mak 12:69. 2012
    ..This study examines the timing of software implementation by individual VHA laboratories and factors associated with implementation...
  60. ncbi request reprint Underuse of aspirin in a referral population with documented coronary artery disease
    Robert M Califf
    Centers for Education and Research on Therapeutics CERTs, Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    Am J Cardiol 89:653-61. 2002
    ..The health care system currently lacks effective methods to ensure that patients who have CAD have adequate follow-up concerning aspirin use...
  61. ncbi request reprint From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes
    Eric D Peterson
    Duke Clinical Research Institute, Durham, North Carolina 27710, USA
    J Am Coll Cardiol 42:1611-6. 2003
    ..We also identified important risk factors for TMR and compared outcomes of TMR combined with coronary artery bypass graft surgery (TMR + CABG) versus bypass alone in patients receiving incomplete revascularization...